The Peptide Directory

Not approved (research only)Synthetic peptide related to thymosin beta-4Recovery

TB-500

Not FDA-approved. Included in the July 23, 2026 advisory vote (8–6) recommending 503A compounding; FDA has not acted.

Last reviewed by The Peptide Directory Editorial Team

What is TB-500?

TB-500 is a synthetic peptide marketed as a version or fragment of thymosin beta-4, a naturally occurring 43-amino-acid protein that binds actin and is involved in cell migration and wound repair; it is not FDA-approved.

Key takeaways

  1. Research on the parent protein, thymosin beta-4, includes eye and wound-healing studies.
  2. Products sold as "TB-500" vary; the label name does not guarantee a specific sequence.
  3. FDA advisers voted 8–6 in July 2026 to recommend it for compounding, against FDA staff advice.
  4. Classified as a doping substance in sport.

Structure

Amino-acid sequence of TB-500, 43 residues: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH

Sequence (43 residues, one-letter code): UniProt P62328; its molecular formula matches PubChem CID 45382195.

What makes TB-500 different?

The parent protein thymosin beta-4 has been tested in formal clinical development (for example in eye-surface disease), but TB-500 itself — the product sold online — has not.

How does TB-500 work?

Thymosin beta-4 sequesters G-actin, which influences cell movement, new blood-vessel formation and inflammation in experimental models.

What the clinical evidence actually shows

  • Reviews describe the biology of beta-thymosins and the bench-to-bedside path of thymosin beta-4 in eye disease.
  • No adequately powered human trials of the product sold as TB-500 for musculoskeletal recovery were identified.

How much research exists on TB-500 (thymosin beta-4 fragment)?

PubMed indexes 602 papers mentioning TB-500 (thymosin beta-4 fragment) in the title or abstract, 92 of them from the last five years and 3 tagged as clinical trials (search run October 19, 2026; repeat the search).

Most relevant recent papers

Registered clinical studies

ClinicalTrials.gov lists 18 studies with TB-500 (thymosin beta-4 fragment) as an intervention (see all). Most recent:

Side effects

Human safety data for TB-500 products are lacking. Risks include unknown long-term effects and impurity or mislabeling in unregulated supply.

Regulatory & access status

  • Not FDA-approved.
  • July 23, 2026: included in the 8–6 advisory vote recommending the 503A bulks list; not yet adopted by FDA.

Sourcing & safety

Sold online as a research chemical, not for human use. Verify any vendor COA for identity (mass spectrometry), not just HPLC purity.

Doses in labels and trials

Reference only — copied from published research. Not a recommendation.

SourceWhat it says
Human doseNo established or approved human dose exists for TB-500.

What the evidence does not show

  • Effectiveness of TB-500 products for injury recovery in humans.
  • Equivalence between "TB-500" products and thymosin beta-4.
  • Long-term safety.

TB-500 FAQ

Is TB-500 the same as thymosin beta-4?

Not exactly. TB-500 is marketed as a synthetic version or fragment of thymosin beta-4; product composition varies by seller.

Is TB-500 FDA-approved?

No. It was among the peptides FDA advisers voted to recommend for compounding in July 2026, but the FDA has not acted on that vote.

Is TB-500 allowed in sport?

No — it is classified as a doping substance.

Related peptides & comparisons

BPC-157GHK-Cu BPC-157 vs TB-500 Injury & Recovery

References

  1. beta-Thymosins, Ann N Y Acad Sci (2007), PMID 17468232
  2. Thymosin beta 4 and the eye: the journey from bench to bedside, Expert Opin Biol Ther (2018), PMID 30063853
  3. July 23–24, 2026: Meeting of the Pharmacy Compounding Advisory Committee, FDA (2026)
  4. FDA Panel Backs 6 Peptides for Compounding, AJMC (2026)
  5. Thymosin beta-4 — PubChem compound summary (CID 45382195), PubChem

TB-500 calculators

Lab arithmetic only: convert a mass to a volume or syringe units at a known concentration with the units converter, or work out a concentration with the reconstitution calculator.

There is no FDA-approved TB-500 product. Compounded versions depend on FDA's compounding rules, and "research use only" products are not for human use.

Get TB-500 via telehealth

None of the telehealth providers we have verified lists TB-500.

Research suppliers that list TB-500

43 vendors in our directory listed a product matching TB-500 in their public catalog on October 19, 2026. Listed alphabetically; a listing is not an endorsement. Research use only.

Prices per mg, where we could verify them, are on our price comparison.

TB-500 dosing protocol

There is no FDA-label or published-trial dosing schedule we can reproduce for TB-500, so we don't publish one.

Find clinics offering TB-500

22 verified clinics name TB-500; browse them by state.

Browse all clinics